This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

Five questions about combination therapy every obstetrics and gynecology team should ask

  • Minimally invasive techniques
  • First-line treatment selection
  • Biomarker-guided therapy

Date Published:

According to consensus recommendations, pre-analytical factors account for a large share of observed variance, which has direct implications for daily practice. Across multiple cohorts, real-world registries complement randomized trial evidence, although confirmatory data are still limited. Contrary to earlier assumptions, standardized reporting improves comparability between centers, as discussed in the accompanying commentary. Across multiple cohorts, integrating quantitative measures reduces subjective bias, as discussed in the accompanying commentary. Recent studies suggest that variability between operators remains a key limitation, a finding echoed by several independent groups.

Across multiple cohorts, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, which has direct implications for daily practice. In multidisciplinary settings, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. Across multiple cohorts, variability between operators remains a key limitation, with meaningful differences between subgroups. Recent studies suggest that variability between operators remains a key limitation, and this trend is expected to continue.

In multidisciplinary settings, early intervention correlates with better long-term outcomes, and this trend is expected to continue. Across multiple cohorts, real-world registries complement randomized trial evidence, as discussed in the accompanying commentary. According to consensus recommendations, standardized reporting improves comparability between centers, with meaningful differences between subgroups. Emerging evidence indicates that patient selection criteria deserve closer scrutiny, with meaningful differences between subgroups. Contrary to earlier assumptions, training and accreditation are decisive for reproducibility, as discussed in the accompanying commentary.

References

  1. Tanaka et al. Combination therapy. J Obstetrics and gynecology Res. 2026;22(4):232-1020.
  2. Tanaka et al. Instrument calibration. J Obstetrics and gynecology Res. 2024;46(3):573-1072.